Olmedo Martín, Raúl Vicente <br/><br/>
Efficacy and safety of vedolizumab as a treatment option for moderate to severe refractory ulcerative colitis in two patients after liver transplant due to primary sclerosing cholangitis.  [electronic resource] 

 -  Revista espanola de enfermedades digestivas  Sep 2017 
 - 659-662 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1130-0108 
<br/><br/><label>Standard No.: </label>10.17235/reed.2017.5024/2017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Cholangitis, Sclerosing--surgery<br/>Colitis, Ulcerative--drug therapy<br/>Female<br/>Gastrointestinal Agents--adverse effects<br/>Humans<br/>Liver Transplantation<br/>Treatment Outcome